| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |